Mallinckrodt Defends Price Hike As Necessary To Save Drug

By Bryan Koenig · October 29, 2019, 7:01 PM EDT

Mallinckrodt has urged a California federal judge to toss Humana's $700 million price-gouging lawsuit over an infant seizure syndrome treatment, arguing that the insurer cannot rely on settlements with federal antitrust...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Humana, Inc. v. Mallinckrodt ARD LLC et al

Case Number

2:19-cv-06926

Court

California Central

Nature of Suit

Anti-Trust

Date Filed

August 08, 2019